Sergio Benavente Norza Radiation Oncologist with a special interest in head and neck cancer, skull base tumors, spinal metastases and high-precision radiation technology including radiosurgery and SBRT Institutions of which they are part Vall Hebron Institut de Recerca Oncologia Radioteràpica General Hospital Twitter Orcid Sergio Benavente Norza Twitter Orcid Institutions of which they are part Vall Hebron Institut de Recerca Oncologia Radioteràpica General Hospital Radiation Oncologist with a special interest in head and neck cancer, skull base tumors, spinal metastases and high-precision radiation technology including radiosurgery and SBRT
Oncologist specialized in radiotherapy in 2002 at Vall d'Hebron Hospital and doctorate from UAB in 2016. At the end of the residency I spent 3 years doing translational research at the Department of Oncology of the University of Wisconsin-Madison (US) where I worked on modulating the effects of radiation with targeted drugs. In 2006 I returned to the Radiation Oncology Department at Vall d'Hebron Hospital until today. My daily work is focused on the treatment of head and neck cancer and on techniques with high precision of irradiation. Initially treating brain metastases with radiosurgery and gradually opening new areas with hypofractionated techniques, vertebral metastases, skull base and functional disorders, reirradiations. We are one of the few centers that currently have committees dedicated to brain and spinal metastases in order to offer patients the best possible treatment and recovery options. Until 2019, I participated in the safety nucleus in radiotherapy dedicated to detecting incidents that could affect the safety of radiation treatments in order to be able to formulate approaches that could avoid them. I regularly participate in clinical trials evaluating the role of irradiation in my areas of interest in order to be able to offer the latest innovations to patients receiving treatment.
Projects Establecimiento de una estrategia combinada en carcinoma escamoso de cabeza y cuello (HNSCC): una herramienta eficaz para superar los tumores quimiorresistentes. IP: Matilde Lleonart Pajarin Collaborators: Katerin Ingrid Rojas Laimito, Yoelsis Garcia Mayea, Juan Lorente Guerrero, Sergio Benavente Norza, Josep Castellví Vives, Marina Bataller Fernández, Pablo Sanchez Sancho, Almudena Sanchez Garcia, Juan Fernando Fuentes Cabrera, Juan Fernando Fuentes Cabrera Funding agency: Instituto de Salud Carlos III Funding: 240000 Reference: PI24/00630 Duration: 01/01/2025 - 31/12/2027 New therapeutic approaches in head and neck cancer IP: Matilde Lleonart Pajarin Collaborators: Irene Braña Garcia, Yoelsis Garcia Mayea, Jordi Temprana Salvador, Angel García Jiménez, Sergio Benavente Norza, Josep Castellví Vives, Laia Josa Culleré, Marina Bataller Fernández Funding agency: Instituto de Salud Carlos III Funding: 183920 Reference: PI20/00556 Duration: 01/01/2021 - 30/06/2025 GC16173720CARR Definición de mecanismos clave de la multiresistencia de tumores de cabeza y cuello a los tratamientos quimio- y radioterapéuticos. Identificación de nuevos antitumorales individualizados. IP: Matilde Lleonart Pajarin Collaborators: Yoelsis Garcia Mayea, Juan Lorente Guerrero, Sergio Benavente Norza, Josep Castellví Vives, Vicente Peg Camara, Almudena Sanchez Garcia Funding agency: Asociación Española Contra el Cáncer Funding: 380000 Reference: AECC/GCE/2016/LLEONART Duration: 01/10/2016 - 30/09/2022 Nuevas terapias aplicables a cánceres mamarios de naturaleza agresiva y metastática en base a aniquilar la población de células madre de cáncer. IP: Matilde Lleonart Pajarin Collaborators: Irene Braña Garcia, Margarita Alberola Ferranti, Sergio Benavente Norza, Carmela Iglesias i Felip, Josep Castellví Vives, Maria Alsina Maqueda Funding agency: Instituto de Salud Carlos III Funding: 195415 Reference: PI15/01262 Duration: 01/01/2016 - 30/11/2020
